Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Top Cited Papers
Open Access
- 3 March 2003
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 197 (5) , 633-642
- https://doi.org/10.1084/jem.20021756
Abstract
The study of hepatitis C virus (HCV), a major cause of chronic liver disease, has been hampered by the lack of a cell culture system supporting its replication. Here, we have successfully generated infectious pseudo-particles that were assembled by displaying unmodified and functional HCV glycoproteins onto retroviral and lentiviral core particles. The presence of a green fluorescent protein marker gene packaged within these HCV pseudo-particles allowed reliable and fast determination of infectivity mediated by the HCV glycoproteins. Primary hepatocytes as well as hepato-carcinoma cells were found to be the major targets of infection in vitro. High infectivity of the pseudo-particles required both E1 and E2 HCV glycoproteins, and was neutralized by sera from HCV-infected patients and by some anti-E2 monoclonal antibodies. In addition, these pseudo-particles allowed investigation of the role of putative HCV receptors. Although our results tend to confirm their involvement, they provide evidence that neither LDLr nor CD81 is sufficient to mediate HCV cell entry. Altogether, these studies indicate that these pseudo-particles may mimic the early infection steps of parental HCV and will be suitable for the development of much needed new antiviral therapies.Keywords
This publication has 63 references indexed in Scilit:
- Relationship between SU Subdomains That Regulate the Receptor-Mediated Transition from the Native (Fusion-Inhibited) to the Fusion-Active Conformation of the Murine Leukemia Virus GlycoproteinJournal of Virology, 2002
- Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primatesBlood, 2002
- Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing ParticlesJournal of Virology, 2002
- Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell–activating polypeptideBlood, 2002
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsGene Therapy, 2000
- The Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins E1 and E2 Play a Major Role in HeterodimerizationJournal of Biological Chemistry, 2000
- Clinical Significance of Hepatitis C Virus GenotypesClinical Microbiology Reviews, 2000
- Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 GlycoproteinJournal of Virology, 2000
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996